Telomir Pharma Raises $5.6M for TNBC Trial
October 6, 2026 — Telomir Pharmaceuticals (NASDAQ: TELO) secures $5.6M PIPE financing to advance Telomir-Zn into Phase 1/2 trials for triple-negative breast cancer. FDA IND cleared.
Curated Business Corporate News
NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
NanoViricides to Present at NIBA Conference, Advancing Broad-Spectrum Antiviral NV-387
October 6, 2026 — NanoViricides to present at NIBA 153rd Investment Conference on Oct 7, 2026. Lead drug NV-387 in Phase 2 trials for Ebola and Mpox, with plans for measles and other viruses.
Middle-Class Renters Finally Noticed in New Federal Housing Measure
October 6, 2026 — New federal housing measure directs GAO to study middle-class income definition. OneWall Communities CEO Ron Kutas says it's a signal, not a solution, and calls for preservation incentives.
Quantum BioPharma Advances Phase 2 MS Trial with Thermo Fisher Partnership
October 6, 2026 — Quantum BioPharma partners with Thermo Fisher to launch Phase 2 trial of Lucid-MS, a novel multiple sclerosis treatment targeting PAD2 to prevent myelin degradation.
Europe Ecommerce Growth to Slow to 5% in 2026, Reaching €961B
October 6, 2026 — Europe ecommerce sales to grow 5% in 2026, reaching €961B, down from 7% in 2025. Alibaba and others eye expansion as market matures. Read the full report.
Greenland Mines Authorizes $20 Million Share Buyback
October 6, 2026 — Greenland Mines (NASDAQ: GRML) authorizes $20M share buyback after $59M raise, funding Sarfartoq and Skaergaard projects through 2027 milestones.
Amazon Backs Shetland Wind Farm in Latest UK Renewables Push
October 6, 2026 — Amazon signs a power deal for a Shetland wind farm, expanding its UK renewables portfolio past 50 projects with Statkraft's Mossy Hill site set for 2030.
Dry September Shrinks Clay Soil, Threatening Sanford Home Pipes
October 6, 2026 — Comfort First Heating and Cooling warns that Sanford's dry September has shrunk clay soil, risking hidden pipe leaks. Learn signs and prevention tips.
Fredericksburg Heating Expert: Test Your Furnace Before First Frost
October 6, 2026 — Fredericksburg heating contractor Robert B. Payne urges homeowners to test furnaces and heat pumps before the average first frost on Oct. 27. Get tips and service.
Returning Snowbirds: Check Plumbing First, Warns Bullseye
October 6, 2026 — Bullseye Home Services warns returning snowbirds to check plumbing first. Hidden leaks, water heater issues, and dried drain traps can cause costly damage. Get expert tips and repairs in Osprey, FL.
Rezolve Ai Secures Court Approval for $300M Share Buyback Program
October 6, 2026 — Rezolve Ai (NASDAQ: RZLV) wins court approval for capital reduction, paving the way for a $300M share buyback program to boost shareholder value.
Rezolve Ai Hosts Investor Day, Releases Shocking AI Visibility Study
October 6, 2026 — Rezolve Ai hosts Investor Day and releases a study showing 1 in 4 companies are invisible to AI assistants. Learn how agentic commerce is reshaping retail.
Beeline Holdings Eyes Record Q3 2026 Revenue and Margins, Launches HEI Product
October 6, 2026 — Beeline Holdings (NASDAQ: BLNE) expects record Q3 2026 revenue and margins, launches Home Equity Investment product to broaden platform and reduce rate dependence.
Datavault AI Appoints Christopher R. Hardt to Board of Directors
October 6, 2026 — Datavault AI appoints Christopher R. Hardt to its board of directors. Hardt brings 30+ years of financial expertise to support the company's AI-driven data platform growth.
Okogen Gets CDSCO Nod for Treyegen™ Phase 1/2 Conjunctivitis Study
October 6, 2026 — Okogen wins CDSCO authorization for EMERALD Phase 1/2 trial of Treyegen™ (OKG-0303) in acute infectious conjunctivitis, enrolling 300+ patients in India.
A2Z Cust2Mate Acquires Hedia in $8.4M Cash and Stock Deal
October 6, 2026 — A2Z Cust2Mate completes acquisition of Hedia, an Israeli retail media firm with $20M revenue, combining smart carts and retail media to transform in-store commerce.
Kairos Pharma's ENV-105 Combo Triples PFS in Prostate Cancer Trial
October 6, 2026 — Kairos Pharma's ENV-105 plus apalutamide shows 17.7-month PFS in prostate cancer trial, a significant improvement over apalutamide alone. Interim Phase 2 data.
AXIM Submits 510(k) for Rapid Dry Eye Test, Eyes CLIA Waiver
October 6, 2026 — AXIM Biotechnologies submits 510(k) to FDA for a rapid, point-of-care dry eye test measuring lactoferrin. Plans CLIA waiver to expand access in eye care offices.
GeoVax to Present Single-Dose MVA and Continuous Cell-Line Manufacturing Advances at World Vaccine Congress Europe 2026
October 6, 2026 — GeoVax to present at World Vaccine Congress Europe 2026 on single-dose MVA-X and continuous cell-line manufacturing, advancing scalable vaccine production.
HKCEC Hosts 786 Events, Cementing Hong Kong as Global Convention Hub
October 6, 2026 — HKCEC hosted 786 events in FY 2025-2026, drawing 7.7 million attendees and reinforcing Hong Kong's status as a global convention and exhibition hub.